These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16445431)

  • 41. Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis.
    Fleischer AB; Abramovits W; Breneman D; Jaracz E;
    J Dermatolog Treat; 2007; 18(3):151-7. PubMed ID: 17538803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atopic dermatitis among 2-year olds; high prevalence, but predominantly mild disease--the PACT study, Norway.
    Smidesang I; Saunes M; Storrø O; Øien T; Holmen TL; Johnsen R; Henriksen AH
    Pediatr Dermatol; 2008; 25(1):13-8. PubMed ID: 18304146
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term treatment with 0.1% tacrolimus ointment in adults with atopic dermatitis: results of a two-year, multicentre, non-comparative study.
    Reitamo S; Ortonne JP; Sand C; Bos J; Cambazard F; Bieber T; Grønhøj-Larsen C; Rustin M; Fölster-Holst R; Schuttelaar M;
    Acta Derm Venereol; 2007; 87(5):406-12. PubMed ID: 17721647
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sustained efficacy and safety of pimecrolimus cream 1% when used long-term (up to 26 weeks) to treat children with atopic dermatitis.
    Langley RG; Eichenfield LF; Lucky AW; Boguniewicz M; Barbier N; Cherill R
    Pediatr Dermatol; 2008; 25(3):301-7. PubMed ID: 18577032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults.
    Hon KL; Ching GK; Leung TF; Chow CM; Lee KK; Ng PC
    J Dermatolog Treat; 2009; 20(3):141-5. PubMed ID: 18951236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in nutritional status on follow-up of an incident cohort of continuous ambulatory peritoneal dialysis patients.
    Prasad N; Gupta A; Sinha A; Sharma RK; Kumar A; Kumar R
    J Ren Nutr; 2008 Mar; 18(2):195-201. PubMed ID: 18267212
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An 18-month-old who could not walk: a case report.
    Hartman AL; Benjamin JT
    Clin Pediatr (Phila); 2002; 41(9):731-2; discussion 732-4. PubMed ID: 12462327
    [No Abstract]   [Full Text] [Related]  

  • 48. Vitamin D dependent rickets type II: late onset of disease and response to high doses of vitamin D.
    Soni SS; Adikey GK; Raman AS
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):796-8. PubMed ID: 18711299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Itch intensity evaluated in the German Atopic Dermatitis Intervention Study (GADIS): correlations with quality of life, coping behaviour and SCORAD severity in 823 children.
    Weisshaar E; Diepgen TL; Bruckner T; Fartasch M; Kupfer J; Lob-Corzilius T; Ring J; Scheewe S; Scheidt R; Schmid-Ott G; Schnopp C; Staab D; Szcepanski R; Werfel T; Wittenmeier M; Wahn U; Gieler U
    Acta Derm Venereol; 2008; 88(3):234-9. PubMed ID: 18480921
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life.
    McKenna SP; Whalley D; de Prost Y; Staab D; Huels J; Paul CF; van Assche D
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):248-54. PubMed ID: 16503881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cushing's syndrome induced by misuse of moderate- to high-potency topical corticosteroids.
    Coureau B; Bussières JF; Tremblay S
    Ann Pharmacother; 2008 Dec; 42(12):1903-7. PubMed ID: 19017822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patch testing: another steroid-sparing agent to consider in children.
    Jacob SE; Burk CJ; Connelly EA
    Pediatr Dermatol; 2008; 25(1):81-7. PubMed ID: 18304161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Plasma concentration of 25-hydroxycholecalciferol in infants].
    Larracilla-Alegre J; Villalpando S; León-Jiménez G; Luengas-Bartels J
    Bol Med Hosp Infant Mex; 1984 Jul; 41(7):374-6. PubMed ID: 6477700
    [No Abstract]   [Full Text] [Related]  

  • 54. Long-term follow-up of atopic dermatitis: retrospective analysis of related risk factors and association with concomitant allergic diseases.
    Ricci G; Patrizi A; Baldi E; Menna G; Tabanelli M; Masi M
    J Am Acad Dermatol; 2006 Nov; 55(5):765-71. PubMed ID: 17052480
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis.
    Neumann E; Amtage D; Bruckner-Tuderman L; Mockenhaupt M
    J Dtsch Dermatol Ges; 2008 Jul; 6(7):548-53. PubMed ID: 18248495
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Computer aided design mapping for SCORAD index in atopic dermatitis--accessible and economical.
    Kanthraj GR
    Pediatr Allergy Immunol; 2005 Mar; 16(2):182-3. PubMed ID: 15787878
    [No Abstract]   [Full Text] [Related]  

  • 57. Atopic dermatitis and alternative management strategies.
    Anderson PC; Dinulos JG
    Curr Opin Pediatr; 2009 Feb; 21(1):131-8. PubMed ID: 19242250
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The differential diagnosis of atopic dermatitis in childhood.
    Krol A; Krafchik B
    Dermatol Ther; 2006; 19(2):73-82. PubMed ID: 16669989
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
    Wollenberg A; Reitamo S; Girolomoni G; Lahfa M; Ruzicka T; Healy E; Giannetti A; Bieber T; Vyas J; Deleuran M;
    Allergy; 2008 Jul; 63(7):742-50. PubMed ID: 18592619
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Top 10 vitamin D myths.
    Plotnikoff GA
    Minn Med; 2005 Nov; 88(11):38-41. PubMed ID: 16475401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.